Malignant Lip and Oral Cavity Neoplasm — Trials

Malignant Lip and Oral Cavity Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

554 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 149
Recruiting: 77
Ph III recruiting: 11
Growth YoY: +4.8%
Industry share: 5%
Top sponsor: National Cancer Institute (NCI)
Termination share: 26.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (53)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02236936	Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck(AGMT_HNO_PN)	terminated	Phase 3	8	Arbeitsgemeinschaft medikamentoese TumortherapieOTHER	1	May 1, 2020	clinicaltrials
NCT00934739	A Study of High-Risk Oral Cavity Cancer	terminated	Phase 2 / Phase 3	150	National Health Research Institutes, TaiwanOTHER	0	Feb 25, 2015